Karyopharm Therapeutics Inc (KPTI) is near the middle in its industry group according to InvestorsObserver. KPTI gets an overall rating of 41. That means it scores higher than 41 percent of stocks. Karyopharm Therapeutics Inc gets a 38 rank in the Biotechnology industry. Biotechnology is number 38 out of 148 industries.
KPTI has an Overall Score of 41. Find out what this means to you and get the rest of the rankings on KPTI!